Experience

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Wix.com Ltd. of $575 million aggregate principal amount of its 0%…

Davis Polk advised the joint book-running managers on a Rule 144A / Regulation S offering by Wyndham Hotels & Resorts, Inc. of $500 million aggregate principal amount of 4.375%…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atreca, Inc. of its common stock for up to an aggregate amount of $100 million. Atreca is a…

Davis Polk advised the initial purchasers in connection with a $200 million Regulation S only offering by China South City Holdings Limited of its 11.500% senior notes due 2021. CSC is a…

Davis Polk advised the initial purchasers in connection with a $200 million Regulation S high-yield offering by KWG Group Holdings Limited of its 5.950% senior notes due 2025. KWG Group…

Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $550 million principal amount of 3.000% senior secured notes due…

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Bloom Energy Corporation of $200 million aggregate principal amount of its 2.500% green convertible…

Davis Polk advised the initial purchasers on a Rule 144A and Regulation S reopening of $50 million aggregate principal amount of 7.500% senior secured notes due 2028 of AI Candelaria …

Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American depositary shares representing 8,823,529 ordinary shares, which…

Davis Polk advised the representatives of the underwriters in connection with an approximately $963.5 million public offering of ordinary shares of Horizon Therapeutics Public Limited…